PMEF
NGM

Point72 Middle East FZE’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Point72 Middle East FZE’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,771
Closed -$30.8K – 1489
2023
Q3 		$30.8K Buy
+28,771
New +$30.8K ﹤0.01% 766
2023
Q2 		– Sell
-5,441
Closed -$22.2K – 1620
2023
Q1 		$22.2K Buy
5,441
+2,203
+68% +$8.99K ﹤0.01% 866
2022
Q4 		$16.3K Buy
+3,238
New +$16.3K ﹤0.01% 1126